Amedisys Stock Current Valuation

AMED Stock

USD 91.79 0.63 0.69%

Valuation analysis of Amedisys helps investors to measure Amedisys' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value Over EBITDA is expected to grow to 16.65. The current year's Enterprise Value Multiple is expected to grow to 16.65. Fundamental drivers impacting Amedisys' valuation include:

Price Book

2.8149

Enterprise Value

3.4 B

Enterprise Value Ebitda

26.1218

Price Sales

1.3424

Forward PE

20.284

Fairly Valued

Today

91.79

Please note that Amedisys' price fluctuation is very steady at this time. Calculation of the real value of Amedisys is based on 3 months time horizon. Increasing Amedisys' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.

Buy or Sell Advice Valuation Matrix

Our valuation method for Amedisys is useful when determining the fair value of the Amedisys stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Amedisys. Since Amedisys is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amedisys Stock. However, Amedisys' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.

Historical

Market 91.79

Real 94.13

Target 96.1

Hype 91.77

The real value of Amedisys Stock, also known as its intrinsic value, is the underlying worth of Amedisys Company, which is reflected in its stock price. It is based on Amedisys' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Amedisys' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amedisys' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.

82.61

Downside

94.13

Real Value

Target Odds

Above Odds

Below Odds

94.55

Upside

Estimating the potential upside or downside of Amedisys helps investors to forecast how Amedisys stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amedisys more accurately as focusing exclusively on Amedisys' fundamentals will not take into account other important factors:

Earnings

Estimates (0)

Low	Projected	High
1.11	1.25	1.51

Details

Hype

Prediction

Low	Estimated	High
91.35	91.77	92.19

Details

10 Analysts

Consensus

Low	Target Price	High
87.45	96.10	106.67

Details

Amedisys Company Current Valuation Analysis

Amedisys' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Amedisys Current Valuation

3.43 B

Most of Amedisys' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amedisys is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Amedisys Current Valuation Driver Correlations

Understanding the fundamental principles of building solid financial models for Amedisys is extremely important. It helps to project a fair market value of Amedisys Stock properly, considering its historical fundamentals such as Current Valuation. Since Amedisys' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Amedisys' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Amedisys' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Current Deferred Revenue	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Good Will	Intangible Assets	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.9	0.95	0.6	0.95	0.99	0.95	0.9	0.76	0.53	0.94	-0.92	-0.24	0.98	0.89	-0.81	0.29	0.88	0.85	0.4	0.72	0.8	0.91	-0.64	0.81
Total Stockholder Equity	0.99		0.86	0.93	0.64	0.97	0.97	0.95	0.88	0.76	0.58	0.92	-0.9	-0.24	0.97	0.88	-0.75	0.27	0.84	0.85	0.35	0.71	0.79	0.88	-0.62	0.79
Net Debt	0.9	0.86		0.9	0.56	0.78	0.91	0.74	0.83	0.63	0.37	0.98	-0.88	-0.17	0.92	0.91	-0.87	0.34	0.9	0.76	0.5	0.76	0.62	0.94	-0.56	0.65
Retained Earnings	0.95	0.93	0.9		0.47	0.87	0.94	0.85	0.87	0.81	0.29	0.94	-0.95	-0.37	0.98	0.88	-0.92	0.49	0.94	0.81	0.63	0.78	0.81	0.95	-0.66	0.84
Accounts Payable	0.6	0.64	0.56	0.47		0.66	0.58	0.56	0.43	0.13	0.78	0.52	-0.59	-0.05	0.57	0.72	-0.33	0.07	0.26	0.69	0.06	0.31	0.08	0.51	-0.6	0.17
Net Receivables	0.95	0.97	0.78	0.87	0.66		0.93	0.98	0.84	0.7	0.61	0.84	-0.88	-0.3	0.92	0.84	-0.68	0.34	0.76	0.86	0.34	0.66	0.76	0.8	-0.64	0.76
Total Liab	0.99	0.97	0.91	0.94	0.58	0.93		0.93	0.9	0.73	0.49	0.95	-0.91	-0.23	0.98	0.89	-0.84	0.31	0.89	0.84	0.44	0.69	0.79	0.92	-0.67	0.81
Total Current Assets	0.95	0.95	0.74	0.85	0.56	0.98	0.93		0.85	0.73	0.57	0.82	-0.83	-0.3	0.9	0.78	-0.66	0.29	0.76	0.82	0.3	0.63	0.82	0.78	-0.58	0.81
Short Term Debt	0.9	0.88	0.83	0.87	0.43	0.84	0.9	0.85		0.74	0.33	0.85	-0.75	-0.06	0.87	0.77	-0.72	0.32	0.84	0.65	0.36	0.61	0.8	0.83	-0.49	0.81
Current Deferred Revenue	0.76	0.76	0.63	0.81	0.13	0.7	0.73	0.73	0.74		0.16	0.71	-0.68	-0.4	0.76	0.56	-0.66	0.27	0.81	0.59	0.37	0.75	0.9	0.74	-0.22	0.85
Common Stock	0.53	0.58	0.37	0.29	0.78	0.61	0.49	0.57	0.33	0.16		0.39	-0.42	0.12	0.42	0.57	-0.08	-0.25	0.14	0.67	-0.26	0.34	0.17	0.36	-0.36	0.28
Long Term Debt	0.94	0.92	0.98	0.94	0.52	0.84	0.95	0.82	0.85	0.71	0.39		-0.89	-0.23	0.96	0.91	-0.88	0.33	0.95	0.79	0.47	0.79	0.74	0.96	-0.54	0.74
Treasury Stock	-0.92	-0.9	-0.88	-0.95	-0.59	-0.88	-0.91	-0.83	-0.75	-0.68	-0.42	-0.89		0.42	-0.96	-0.89	0.89	-0.52	-0.85	-0.9	-0.68	-0.76	-0.68	-0.91	0.78	-0.74
Property Plant Equipment	-0.24	-0.24	-0.17	-0.37	-0.05	-0.3	-0.23	-0.3	-0.06	-0.4	0.12	-0.23	0.42		-0.34	-0.19	0.45	-0.54	-0.35	-0.41	-0.61	-0.25	-0.37	-0.3	0.36	-0.37
Good Will	0.98	0.97	0.92	0.98	0.57	0.92	0.98	0.9	0.87	0.76	0.42	0.96	-0.96	-0.34		0.91	-0.89	0.4	0.92	0.86	0.54	0.75	0.79	0.95	-0.68	0.81
Intangible Assets	0.89	0.88	0.91	0.88	0.72	0.84	0.89	0.78	0.77	0.56	0.57	0.91	-0.89	-0.19	0.91		-0.82	0.34	0.81	0.9	0.43	0.79	0.58	0.94	-0.63	0.68
Net Tangible Assets	-0.81	-0.75	-0.87	-0.92	-0.33	-0.68	-0.84	-0.66	-0.72	-0.66	-0.08	-0.88	0.89	0.45	-0.89	-0.82		-0.57	-0.93	-0.73	-0.78	-0.71	-0.69	-0.93	0.66	-0.73
Total Permanent Equity	0.29	0.27	0.34	0.49	0.07	0.34	0.31	0.29	0.32	0.27	-0.25	0.33	-0.52	-0.54	0.4	0.34	-0.57		0.44	0.37	0.81	0.33	0.32	0.41	-0.5	0.33
Long Term Debt Total	0.88	0.84	0.9	0.94	0.26	0.76	0.89	0.76	0.84	0.81	0.14	0.95	-0.85	-0.35	0.92	0.81	-0.93	0.44		0.71	0.59	0.79	0.85	0.94	-0.47	0.85
Capital Surpluse	0.85	0.85	0.76	0.81	0.69	0.86	0.84	0.82	0.65	0.59	0.67	0.79	-0.9	-0.41	0.86	0.9	-0.73	0.37	0.71		0.46	0.75	0.62	0.85	-0.71	0.73
Deferred Long Term Liab	0.4	0.35	0.5	0.63	0.06	0.34	0.44	0.3	0.36	0.37	-0.26	0.47	-0.68	-0.61	0.54	0.43	-0.78	0.81	0.59	0.46		0.44	0.37	0.55	-0.66	0.45
Long Term Investments	0.72	0.71	0.76	0.78	0.31	0.66	0.69	0.63	0.61	0.75	0.34	0.79	-0.76	-0.25	0.75	0.79	-0.71	0.33	0.79	0.75	0.44		0.66	0.82	-0.25	0.71
Short Long Term Debt	0.8	0.79	0.62	0.81	0.08	0.76	0.79	0.82	0.8	0.9	0.17	0.74	-0.68	-0.37	0.79	0.58	-0.69	0.32	0.85	0.62	0.37	0.66		0.74	-0.32	0.95
Net Invested Capital	0.91	0.88	0.94	0.95	0.51	0.8	0.92	0.78	0.83	0.74	0.36	0.96	-0.91	-0.3	0.95	0.94	-0.93	0.41	0.94	0.85	0.55	0.82	0.74		-0.58	0.79
Net Working Capital	-0.64	-0.62	-0.56	-0.66	-0.6	-0.64	-0.67	-0.58	-0.49	-0.22	-0.36	-0.54	0.78	0.36	-0.68	-0.63	0.66	-0.5	-0.47	-0.71	-0.66	-0.25	-0.32	-0.58		-0.45
Capital Stock	0.81	0.79	0.65	0.84	0.17	0.76	0.81	0.81	0.81	0.85	0.28	0.74	-0.74	-0.37	0.81	0.68	-0.73	0.33	0.85	0.73	0.45	0.71	0.95	0.79	-0.45

Click cells to compare fundamentals

Amedisys Current Valuation Historical Pattern

Today, most investors in Amedisys Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Amedisys' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Amedisys current valuation as a starting point in their analysis.

Amedisys Current Valuation

Timeline

Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Competition

Predict Amedisys

Enterprise Value Over Time

In accordance with the recently published financial statements, Amedisys has a Current Valuation of 3.43 B. This is 76.14% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 79.38% higher than that of the company.

Amedisys Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amedisys' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amedisys could also be used in its relative valuation, which is a method of valuing Amedisys by comparing valuation metrics of similar companies.

Amedisys is currently under evaluation in current valuation category among related companies.

Amedisys Fundamentals

	Return On Equity	-0.0187
	Return On Asset	0.0626
	Profit Margin	(0.01) %
	Operating Margin	0.09 %
	Current Valuation	3.43 B
	Shares Outstanding	32.68 M
	Shares Owned By Insiders	2.26 %
	Shares Owned By Institutions	95.05 %
	Number Of Shares Shorted	2.39 M
	Price To Earning	15.03 X
	Price To Book	2.81 X
	Price To Sales	1.34 X
	Revenue	2.24 B
	Gross Profit	453.98 M
	EBITDA	216.91 M
	Net Income	(9.75 M)
	Cash And Equivalents	17.96 M
	Cash Per Share	0.55 X
	Total Debt	487.21 M
	Debt To Equity	0.53 %
	Current Ratio	1.06 X
	Book Value Per Share	33.30 X
	Cash Flow From Operations	137.19 M
	Short Ratio	8.94 X
	Earnings Per Share	(0.64) X
	Price To Earnings To Growth	1.35 X
	Target Price	97.78
	Number Of Employees	18.7 K
	Beta	0.86
	Market Capitalization	3 B
	Total Asset	2.06 B
	Retained Earnings	747.92 M
	Working Capital	23.21 M
	Current Asset	175.26 M
	Current Liabilities	175.19 M
	Net Asset	2.06 B

About Amedisys Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Amedisys's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amedisys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amedisys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Amedisys

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amedisys position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amedisys will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amedisys Stock

0.82	GH	Guardant Health Financial Report 14th of May 2024	Pair Corr
0.64	IDXX	IDEXX Laboratories Financial Report 7th of May 2024	Pair Corr

Moving against Amedisys Stock

0.71	HCWB	HCW Biologics	Pair Corr
0.66	ELYM	Eliem Therapeutics Upward Rally	Pair Corr
0.65	ACB	Aurora Cannabis Sell-off Trend	Pair Corr
0.62	ELEV	Elevation Oncology Earnings Call This Week	Pair Corr
0.6	CGC	Canopy Growth Corp Financial Report 27th of June 2024	Pair Corr

The ability to find closely correlated positions to Amedisys could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amedisys when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amedisys - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amedisys to buy it.

The correlation of Amedisys is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amedisys moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amedisys moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Amedisys can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:

How To Invest In Amedisys

Details

Is Amedisys Stock a good investment?

Details

What is Amedisys' Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Amedisys Piotroski F Score and Amedisys Altman Z Score analysis.

For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.

Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Amedisys Stock analysis

When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.

	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Commodity Directory Find actively traded commodities issued by global exchanges
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	CEOs Directory Screen CEOs from public companies around the world
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges

Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.43)

Earnings Share

(0.64)

Revenue Per Share

69.004

Quarterly Revenue Growth

0.027

Return On Assets

0.0626

The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Amedisys Stock Current Valuation

Amedisys Company Current Valuation Analysis

Enterprise Value

Market Cap + Debt

-

Cash

Current Amedisys Current Valuation

Amedisys Current Valuation Driver Correlations

Amedisys Current Valuation Historical Pattern

Amedisys Current Valuation Peer Comparison

Amedisys Fundamentals

About Amedisys Fundamental Analysis

Pair Trading with Amedisys

Moving together with Amedisys Stock

Moving against Amedisys Stock

Complementary Tools for Amedisys Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY